Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
ambient cistern
ambient cistern, effacement
amyloid angiopathy, cerebral
aneurysm
aneurysm, intracranial
aneurysm, intracranial, acute deterioration
aneurysm, intracranial, treatment of
angiography, cerebral
anticoagulant, complications of
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticonvulsants
asymptomatic
ataxia
basal ganglia, hemorrhage
basal ganglia, infarction
basilar artery
basilar artery occlusion
blood pressure
blood pressure, control
blood pressure, lowering
brainstem, hematoma
brainstem, hemorrhage, primary
brainstem, vascular malformation of
carotid artery disease
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, mass effect on
CAT scan, stereotactic localization
cerebellar hemorrhage
cerebellar infarction
cerebral embolism, mechanical extraction
cerebral infarction, hemorrhagic
cerebral venous infarction
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, clinical diagnosis
cerebrovascular accident, complications with
cerebrovascular accident, nontreatment of
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time to treatment
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease, surgical treatment of
clot burden
clot length
complications
controversies in neurology
coronary thrombolysis
coumarin
craniectomy, decompressive
craniotomy
critical care unit
disability, neurological
do not resuscitate
door to needle time
drug abuse
dying
efficacy
emergencies, neurologic
emergency room
emergency room, treatment of stroke
endoscopic surgery
endovascular therapy
ENRICH trial
epidemiology of neurology
evidence-based research
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
gadolinium
gastrointestinal bleeding
Glasgow coma score
head injury
headache
hematoma, intracerebral
hemorrhage, putamenal
hemorrhage, thalamic
hemostatic therapy
heralding manifestation
herniation syndromes, intracranial
hydrocephalus
hydrocephalus, treatment of
hypertension
iatrogenic neurologic disorders
incidence
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, differential diagnosis of
intracerebral hemorrhage, incidence of
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, medical management
intracerebral hemorrhage, multiple
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, progression of
intracerebral hemorrhage, recurrent
intracerebral hemorrhage, small
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure monitoring
intracranial pressure, increased
intracranial pressure, increased, treatment of
intraventricular hemorrhage
intraventricular hemorrhage, clot evacuation
intraventricular hemorrhage, treatment
intubation
ischemic core
level of consciousness
level of consciousness, decreased
life expectancy
life support, withdrawal of
life support, withholding of
malformation, vascular
malformation, vascular, cerebral
malformation, vascular, cryptic
microsurgery
middle cerebral artery
middle cerebral artery, occlusion of
minimally invasive surgery
mortality
MRI
MRI, abnormal
MRI, ADC maps
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, gradient echo, vessel sign
MRI, susceptibility weighted
MRI, volumetry
myocardial infarction
myocardial infarction, acute
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS, hemorrhagic
neoplasm, metastatic to CNS-hemorrhage into
neoplasm, primary of CNS
neoplasm, primary of CNS-hemorrhage in
neurologic complications of, surgery
neurologic disease, diagnoses of
neurologic examination
neurological intensive care
patient selection
platelet inhibiting drugs
pontine hemorrhage
practice guidelines
prevention of neurologic disorders
prognosis
race
Rankin score
recanalization, arterial
recombinant activated factor VII
reperfusion
Retriever Device
review article
risk factors
safety
seizure
seizure, prevention of
shunt procedure, ventricular
solitaire device
Spot sign
stereotaxic surgery
STITCH II trial
streptokinase
subarachnoid hemorrhage
subdural hematoma
SWIFT PRIME Trials
syncope
thrombectomy
tissue plasminogen activator, intravenous
tranexamic acid
treatment of neurologic disorder
urokinase
ventriculostomy
ventriculostomy, endoscopic
vertigo
workup
Showing articles 700 to 750 of 1391 << Previous Next >>

Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005

Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005

Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR 26:880-884, Zaidat,O.O.,et al, 2005

Mechanical Thrombectomy for Acute Stroke
AJNR 26:875-879, Versnick,E.J.,et al, 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

IV Thrombolysis in Patients with Acute Stroke Due to Spontaneous Carotid Dissection
Neurol 64:1612-1614, Georgiadis,D.,et al, 2005

Utility of an Ultrafast Magnetic Resonance Imaging Protocol in Recent and Semi-Recent Strokes
JNNP 76:1002-1005,905, U-King-Im,J.M.,et al, 2005

Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005

Time to Hospital Arrival, Use of Thrombolytics, and In-Hospital Outcomes in Ischemic Stroke
Neurol 64:2115-2120, Qureshi,A.I.,et al, 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
Stroke 36:1512-1518, Wojner-Alexandrov,A.,et al, 2005

Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke 36:1452-1456, Rubiera,M.,et al, 2005

Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke, Results of the MERCI Trial
Stroke 36:1432-1440, Smikth,W.D.,et al, 2005

Cerebral Venous Thrombosis: Influence of Risk Factors and Imaging Findings on Prognosis
Clin Neurol Neurosurg 107:371-378, Appenzeller,S.,et al, 2005

Intravenous rt-PA for Acute Stroke: Comparing Its Effectiveness in Younger and Older Patients
JNNP 76:1234-1237, Mouradian,M.S.,et al, 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

REACH Clinical Feasibility of a Rural Telestroke Network
Stroke 36:2018-2020, Hess,D.C.,et al, 2005

Use of Mechanical Extraction Devices in Basilar Artery Occlusion
JNNP 76:1462-1464, Favrole,P.,et al, 2005

Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005

Perfusion Computed Tomography: Prediction of Final Infarct Extent and Stroke Outcome
Ann Neurol 58:672-679,661, Parsons,M.W.,et al, 2005

Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Stroke 36:2500-2503, Demaerschalk,B.M. &Yip,T.R., 2005

Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Stroke 36:2497-2499, Smith,E.E.,et al, 2005

Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (=80 Years) Stroke Patients
Stroke 36:2421-2425, Berrouschot,J.,et al, 2005

Reversal of Dense Signs Predicts Recovery in Acute Ischemic Stroke
Stroke 36:e2490-e2492, Mandava,P. &Kent,T.A., 2005

Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005

Hemostatic Treatment in the Early Stage of Intracerebral Hemorrhage, The Recombinant Factor VIIa Experience
Stroke 36:2321-2322, Kase,C.S., 2005

Endovascular Recanalization of Internal Carotid Artery Occlusion in Acute Ischemic Stroke
AJNR 26:2591-2594, Sugg,R.M.,et al, 2005

Thrombolysis in Stroke Patients Aged 80 Years and Older: Swiss Survey of IV Thrombolysis
Neurol 65:1795-1798,1690, Engelter,S.T.,et al, 2005

Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005

Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005

Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase
Stroke 36:66-73, Hacke,W.,et al, 2005

Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005

Potential Applicability of Recombinant Factor VIIa for Intracerebral Hemorrhage
Stroke 36:2660-2664, Flaherty,M.L.,et al, 2005

tPA By Telephone: Extending the Benefits of a Comprehensive Stroke Center
Neurol 64:154-156, Frey,J.L.,et al, 2005

Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005

Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Approval of the MERCI Clot Retriever-A Critical View
Stroke 36:400-403, Becker, K.J.., & Brott, T.G., 2005

Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005

Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005

Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005

Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
JAMA 293:427-436, The CREATE Trial Group Investigators, 2005

Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004

Clinicopath Conf, Malignant Middle Cerebral Artery Infarction
NEJM 350:707-716, Case 5-2004, 2004

Magnetic Resonance Imaging Improves Detection of Intracerebral Hemorrhage Over Computed Tomography after Intra-Arterial Thrombolysis
Stroke 35:491-495, Greer,D.M.,et al, 2004

Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004



Showing articles 700 to 750 of 1391 << Previous Next >>